Vnitr Lek 2023, 69(8):500-505 | DOI: 10.36290/vnl.2023.100

Rate of repeated hospitalization of patients with cirrhosis and its risk factors

Petra Vrbová, Tomáš Koller
V. interná klinika LF UK a UN Bratislava

Background: Patients with cirrhosis make up a non-negligible part of hospitalized patients and are often hospitalized repeatedly. The aim of our work was to find out what happens to patients after being discharged from the hospital to outpatient care, how often they are re-hospitalized, what their prognosis is, and what are the risk factors for these events.

Methods: Data on consecutive patients hospitalized with complications of cirrhosis at the V. internal clinic were recorded in the database. We monitored demographic, social and basic laboratory parameters along with prognostic indices. We recorded the rate of the first event after discharge within 30 and 90 days, which could be hospitalization or death. Subsequently, we evaluated mortality within 30 and 90 days according to the first event, and finally also the risk factors of death and repeated hospitalization after discharge.

Results: During the monitored period of 2 years, we recorded data on 110 hospitalized patients. For all patients, a minimum of 6 months passed from registration in the database to the evaluation of events after discharge or data censoring. From the whole set, 54 patients (49.1%) were repeatedly hospitalized, the number of repeated hospitalizations was from 1 to 8. Furthermore, 27 patients (24.5%) died without repeated hospitalization and 29 patients (26.4%) survived the observed period without repeated hospitalization. We recorded repeated hospitalization within 30 and 90 days in 12 (11%) and 32 (29.1%) patients. Among 54 repeatedly hospitalized patients, we recorded 30- and 90-day mortality in 2 (3.7%) and 9 (16.7%). Among 27 patients who died without re-hospitalization, we recorded 30- and 90-day mortality in 16 (59.3%) and 21 (77.8%). In multivariate analysis for competing events during follow-up (rehospitalization vs. death), we found that acute alcoholic hepatitis (HR=0.0), INR (HR=0.42), number of people living in the patient's household (HR=1.36), platelets (HR=0.99), and cholelithiasis (HR=2.51) were independent risk factors for rehospitalization. Independent risk factors for death were MELD-Na score (HR=1.09), CLIF-ACLF score (HR=1.99), and homeless status (HR=2.99).

Conclusion: Rehospitalization within 1 and 3 months of discharge was common, but nearly a quarter of patients died without rehospitalization. Risk factors for repeated hospitalization were INR, number of people living in the patient's household, platelets and cholelithiasis. Patients with acute alcoholic hepatitis were repeatedly hospitalized only rarely.

Keywords: cirrhosis, repeated hospitalization, mortality, risk factors.

Accepted: November 27, 2023; Published: December 18, 2023  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Vrbová P, Koller T. Rate of repeated hospitalization of patients with cirrhosis and its risk factors. Vnitr Lek. 2023;69(8):500-505. doi: 10.36290/vnl.2023.100.
Download citation

References

  1. Garg SK, Goyal H, Obaitan I, et al. Incidence and predictors of 30-day hospital readmissions for liver cirrhosis: insights from the United States National Readmissions Database. Ann Transl Med. 2021;9(13):1052. Go to original source... Go to PubMed...
  2. Tapper EB, Halbert B, Mellinger J. Rates of and Reasons for Hospital Readmissions in Patients with Cirrhosis: A Multistate Population - Based Cohorot Study. Clin Gastroenterol Hepatol 2016;14(8):1181-1188. Go to original source... Go to PubMed...
  3. Brůha R. Hepatologie - úvod do problematiky. Vnitr Lek. 2019;65(9):535-537. Go to original source...
  4. Volk ML, Tocco RS, Bazick J, Rakoski MO, et al. Hospital Re­‑Admissions among Patients with Decompesated Cirrhosis. Am J Gastroenterol. 2012;107(2):247-252. Go to original source... Go to PubMed...
  5. Patel A, Koola JD, Matheny ME. Reducing readmissions in patients with cirrhosis: the time to act is now. Ann Transl Med. 2021;9(22):1637. Go to original source... Go to PubMed...
  6. Orman ES, Ghabril M, Emmett TW, Chalasani N. Hospital Readmissions in Patient with cirrhosis: A Systematic Review. J Hosp Med. 2018;13(7):490-495. Go to original source... Go to PubMed...
  7. Mah JM, Dewit Y, Groome P, DjerbouaBooth CHM, Flemming JA. Early hospital readmission and survival in patients with cirrhosis: A population­‑based study. Canadioan Liver Journal. 2019;2(3):109-120. Go to original source... Go to PubMed...
  8. Riggio O, Celsa C, Calvaruso V, et al. Hepatic encephalopathy increases the risk for mortality and hospital readmission in decompensated cirrhotic patients: a prospective multicenter study. Front Med (Lausanne) 2023;10:1184860. Go to original source... Go to PubMed...
  9. Patel R, Poddar P, Choksi D et al. Predictors of 1-month and 3-month Hospital Readmissions in Decompensated Cirrhosis: A prospective Study in a Large Asian Cohorot. Ann Hepatol. 2019;18(1):30-39. Go to original source... Go to PubMed...
  10. Chirapongsathorn S, Poovoraean K, Soonthornworasiri N et al. Thirty­‑day Readmission and Cost Analysis in Patients with Cirrhosis: A Nationwide Population­‑Based Data. Hepatol Commun. 2020;4(3):453-460. Go to original source... Go to PubMed...
  11. Gaspar R, Rodrigues S, Silva M, et al. Predictive models of mortality and hospital readmission of patients with decompensated liver cirrhosis. Dig Liver Di. 2019;51(10):1423-1429. Go to original source... Go to PubMed...
  12. Lavekar A, Raje D, Sadar A, et al. Predictors of Three­‑month Hospital Readmissions and Mortality in Patients with Cirrhosis of Liver. Euroasian J Hepatogastroenterol. 2019; 9(2):71-77. Go to original source... Go to PubMed...
  13. Smethurst K, Gallacher J, Jopson J, et al. Improved outcomes following the implementation of a decompensated cirrhosis discharge bundle. Frontline Gastroenterol. 2021;13(5):409-415. Go to original source... Go to PubMed...




Vnitřní lékařství

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.